Parallel Advisors, LLC Abb Vie Inc. Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 108,805 shares of ABBV stock, worth $18 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

108,805

Previous 110,107 1.18%

Holding current value

$18 Million

Previous $18.9 Million 13.77%

% of portfolio

0.51%

Previous 0.49%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $213,319 - $259,527	-1,302 Reduced 1.18%	108,805 $21.5 Million
Q2 2024 Aug 08, 2024	SELL	$154.79 - $180.76 $207,418 - $242,218	-1,340 Reduced 1.2%	110,107 $18.9 Million
Q1 2024 May 06, 2024	BUY	$159.82 - $182.1 $166,692 - $189,930	1,043 Added 0.94%	111,447 $20.3 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $241,488 - $271,972	-1,755 Reduced 1.56%	110,404 $17.1 Million
Q3 2023 May 20, 2024	BUY	$133.59 - $154.65 $221,625 - $256,564	1,659 Added 1.5%	112,159 $16.7 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $221,625 - $256,564	1,659 Added 1.5%	112,159 $16.7 Million
Q2 2023 May 20, 2024	SELL	$132.51 - $164.9 $174,250 - $216,843	-1,315 Reduced 1.18%	110,500 $14.9 Million
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $174,250 - $216,843	-1,315 Reduced 1.18%	110,500 $14.9 Million
Q1 2023 May 20, 2024	BUY	$144.61 - $166.54 $53,216 - $61,286	368 Added 0.33%	111,815 $17.8 Million
Q1 2023 Apr 25, 2023	BUY	$144.61 - $166.54 $10.9 Million - $12.5 Million	75,111 Added 204.64%	111,815 $17.8 Million
Q4 2022 Feb 03, 2023	BUY	$138.31 - $165.87 $457,391 - $548,532	3,307 Added 9.9%	36,704 $5.94 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $340,490 - $390,520	2,537 Added 8.22%	33,397 $4.48 Million
Q2 2022 Aug 01, 2022	SELL	$137.62 - $174.96 $57,800 - $73,483	-420 Reduced 1.34%	30,860 $4.73 Million
Q1 2022 Apr 28, 2022	SELL	$131.98 - $163.75 $42,497 - $52,727	-322 Reduced 1.02%	31,280 $5.12 Million
Q4 2021 Jan 20, 2022	BUY	$107.43 - $135.93 $350,544 - $443,539	3,263 Added 11.51%	31,602 $4.28 Million
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $19,896 - $22,585	187 Added 0.66%	28,339 $3.06 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $330,043 - $367,687	3,137 Added 12.54%	28,152 $3.17 Million
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $131,660 - $144,941	1,287 Added 5.42%	25,015 $2.71 Million
Q4 2020 Feb 02, 2021	SELL	$80.49 - $108.67 $124,679 - $168,329	-1,549 Reduced 6.13%	23,728 $2.54 Million
Q3 2020 Oct 27, 2020	BUY	$85.91 - $100.83 $69,157 - $81,168	805 Added 3.29%	25,277 $2.21 Million
Q2 2020 Jul 16, 2020	BUY	$73.37 - $98.18 $134,046 - $179,374	1,827 Added 8.07%	24,472 $2.4 Million
Q1 2020 Apr 27, 2020	BUY	$64.5 - $97.79 $838 - $1,271	13 Added 0.06%	22,645 $1.73 Million
Q4 2019 Jan 30, 2020	BUY	$72.13 - $90.25 $6,996 - $8,754	97 Added 0.43%	22,632 $2 Million
Q3 2019 Nov 01, 2019	SELL	$62.98 - $75.72 $401,875 - $483,169	-6,381 Reduced 22.07%	22,535 $1.71 Million
Q2 2019 Aug 05, 2019	BUY	$65.7 - $83.98 $208,071 - $265,964	3,167 Added 12.3%	28,916 $2.1 Million
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $34,018 - $40,038	-441 Reduced 1.68%	25,749 $2.08 Million
Q4 2018 Feb 05, 2019	BUY	$77.85 - $96.01 $57,297 - $70,663	736 Added 2.89%	26,190 $2.41 Million
Q3 2018 Nov 01, 2018	BUY	$88.91 - $98.84 $388,447 - $431,831	4,369 Added 20.72%	25,454 $2.41 Million
Q2 2018 Jul 30, 2018	BUY	$89.78 - $106.23 $415,052 - $491,101	4,623 Added 28.08%	21,085 $1.95 Million
Q1 2018 May 08, 2018	BUY	$92.01 - $123.21 $14,077 - $18,851	153 Added 0.94%	16,462 $1.56 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $33,674 - $36,926	-376 Reduced 2.25%	16,309 $1.58 Million
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $1.17 Million - $1.49 Million	16,685 New	16,685 $1.59 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $1.19 Million - $1.52 Million	-17,077 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	17,077	17,077 $1.19 Million

Others Institutions Holding ABBV

# of Institutions

3,837

Shares Held

1.25B

Call Options Held

15.7M

Put Options Held

11.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Abb Vie Inc. Transaction History